Comparison Overview

MSD

VS

Alembic Pharmaceuticals Limited

MSD

90 E Scott Ave, Rahway, New Jersey, US, 07065
Last Update: 2025-12-09
View Profile
Between 750 and 799
http://www.msd.com

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on Facebook, Instagram, Twitter, and YouTube.

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 35,519
Subsidiaries: 34
12-month incidents
1
Known data breaches
1
Attack type number
1
View Profile

Alembic Pharmaceuticals Limited

Alembic Road, Vadodara, 390003, IN
Last Update: 2025-12-09
Between 750 and 799
http://www.alembic-india.com

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India. Alembic's manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh. The plant at Vadodara has the largest fermentation capacity in India. The Panelav facility houses the API and formulation manufacturing (both US FDA approved) plants. The plant at Baddi, Himachal Pradesh manufactures formulations for the domestic and non-regulated export market. The company has a state of the art Research Centre at Vadodara.

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 13,958
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/msd-global.jpeg
MSD
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/alembic.jpeg
Alembic Pharmaceuticals Limited
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
MSD
100%
Compliance Rate
0/4 Standards Verified
Alembic Pharmaceuticals Limited
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

MSD has 25.0% more incidents than the average of same-industry companies with at least one recorded incident.

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Alembic Pharmaceuticals Limited in 2025.

Incident History — MSD (X = Date, Y = Severity)

MSD cyber incidents detection timeline including parent company and subsidiaries

Incident History — Alembic Pharmaceuticals Limited (X = Date, Y = Severity)

Alembic Pharmaceuticals Limited cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/msd-global.jpeg
MSD
Incidents

Date Detected: 9/2025
Type:Breach
Attack Vector: unauthorized access, supply chain compromise
Blog: Blog
https://images.rankiteo.com/companyimages/alembic.jpeg
Alembic Pharmaceuticals Limited
Incidents

No Incident

FAQ

Both MSD company and Alembic Pharmaceuticals Limited company demonstrate a comparable AI Cybersecurity Score, with strong governance and monitoring frameworks in place.

MSD company has historically faced a number of disclosed cyber incidents, whereas Alembic Pharmaceuticals Limited company has not reported any.

In the current year, MSD company has reported more cyber incidents than Alembic Pharmaceuticals Limited company.

Neither Alembic Pharmaceuticals Limited company nor MSD company has reported experiencing a ransomware attack publicly.

MSD company has disclosed at least one data breach, while the other Alembic Pharmaceuticals Limited company has not reported such incidents publicly.

Neither Alembic Pharmaceuticals Limited company nor MSD company has reported experiencing targeted cyberattacks publicly.

Neither MSD company nor Alembic Pharmaceuticals Limited company has reported experiencing or disclosing vulnerabilities publicly.

Neither MSD nor Alembic Pharmaceuticals Limited holds any compliance certifications.

Neither company holds any compliance certifications.

MSD company has more subsidiaries worldwide compared to Alembic Pharmaceuticals Limited company.

MSD company employs more people globally than Alembic Pharmaceuticals Limited company, reflecting its scale as a Pharmaceutical Manufacturing.

Neither MSD nor Alembic Pharmaceuticals Limited holds SOC 2 Type 1 certification.

Neither MSD nor Alembic Pharmaceuticals Limited holds SOC 2 Type 2 certification.

Neither MSD nor Alembic Pharmaceuticals Limited holds ISO 27001 certification.

Neither MSD nor Alembic Pharmaceuticals Limited holds PCI DSS certification.

Neither MSD nor Alembic Pharmaceuticals Limited holds HIPAA certification.

Neither MSD nor Alembic Pharmaceuticals Limited holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

NXLog Agent before 6.11 can load a file specified by the OPENSSL_CONF environment variable.

Published
Date
2025-12-14
Updated
Date
2025-12-14
Risk Information
cvss3
Base: 8.1
Severity: HIGH
CVSS:3.1/AV:L/AC:H/PR:N/UI:N/S:C/C:H/I:H/A:H
References
Description

uriparser through 0.9.9 allows unbounded recursion and stack consumption, as demonstrated by ParseMustBeSegmentNzNc with large input containing many commas.

Published
Date
2025-12-14
Updated
Date
2025-12-14
Risk Information
cvss3
Base: 2.9
Severity: HIGH
CVSS:3.1/AV:L/AC:H/PR:N/UI:N/S:U/C:N/I:N/A:L
References
Description

A vulnerability was detected in Mayan EDMS up to 4.10.1. The affected element is an unknown function of the file /authentication/. The manipulation results in cross site scripting. The attack may be performed from remote. The exploit is now public and may be used. Upgrading to version 4.10.2 is sufficient to fix this issue. You should upgrade the affected component. The vendor confirms that this is "[f]ixed in version 4.10.2". Furthermore, that "[b]ackports for older versions in process and will be out as soon as their respective CI pipelines complete."

Published
Date
2025-12-14
Updated
Date
2025-12-14
Risk Information
cvss2
Base: 5.0
Severity: LOW
AV:N/AC:L/Au:N/C:N/I:P/A:N
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:L/A:N
cvss4
Base: 5.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

MJML through 4.18.0 allows mj-include directory traversal to test file existence and (in the type="css" case) read files. NOTE: this issue exists because of an incomplete fix for CVE-2020-12827.

Published
Date
2025-12-14
Updated
Date
2025-12-14
Risk Information
cvss3
Base: 4.5
Severity: HIGH
CVSS:3.1/AV:L/AC:H/PR:N/UI:N/S:C/C:L/I:N/A:L
References
Description

A half-blind Server Side Request Forgery (SSRF) vulnerability exists in kube-controller-manager when using the in-tree Portworx StorageClass. This vulnerability allows authorized users to leak arbitrary information from unprotected endpoints in the control plane’s host network (including link-local or loopback services).

Published
Date
2025-12-14
Updated
Date
2025-12-14
Risk Information
cvss3
Base: 5.8
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:H/UI:N/S:C/C:H/I:N/A:N
References